Insulet Corp. (PODD) Misses Q2 EPS by 4c; Guides Q3 Sales
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $145.06 +0.25%
Financial Fact:
Sales and marketing: 22.15M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Sales and marketing: 22.15M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
Insulet Corp. (NASDAQ: PODD) reported Q2 EPS of ($0.30), $0.04 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $51 million versus the consensus estimate of $51.75 million.
Sees Q3 2012 revenue of $53-$57 million, versus the consensus of $56 million.
For earnings history and earnings-related data on Insulet Corp. (PODD) click here.
Sees Q3 2012 revenue of $53-$57 million, versus the consensus of $56 million.
For earnings history and earnings-related data on Insulet Corp. (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (
- Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
- Nortech Systems, Inc. (NSYS) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
